How Does NIPT Testing Work? A Complete Guide for 2026

Learn how NIPT testing works in 2026. Non-invasive prenatal testing uses cell-free DNA to screen for common chromosomal conditions. US-focused guide.

Non-invasive prenatal testing (NIPT) is a blood test that analyzes cell-free DNA from the placenta to screen for common chromosomal abnormalities in a developing baby. The test works by drawing a small sample of the mother’s blood—typically after 10 weeks of pregnancy—and then sequencing the tiny fragments of fetal DNA that circulate naturally in her bloodstream. Because NIPT poses no risk of miscarriage, it has become the preferred first-trimester screening option for millions of US families. This guide explains exactly how NIPT testing works, what it detects, and how it compares with other prenatal screening methods.

What Is NIPT (Non-Invasive Prenatal Testing)?

NIPT, also called cell-free DNA screening, is a type of prenatal screening that examines the relative amount of DNA from each chromosome in the mother’s blood. The test is designed to screen for trisomies (extra copies of a chromosome), such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome). Some NIPT panels also screen for sex chromosome aneuploidies and, with newer technology, can include certain microdeletions. NIPT is not diagnostic—it is a screening test that indicates whether the risk of a condition is elevated. If results are high-risk, follow-up diagnostic tests such as chorionic villus sampling (CVS) or amniocentesis are recommended.

The Science Behind Cell-Free DNA

During pregnancy, cells from the placenta undergo apoptosis and release fragmented DNA into the maternal bloodstream. This cell-free DNA (cfDNA) consists of both maternal and fetal DNA. The fetal fraction—the proportion of fetal cfDNA relative to total cfDNA—typically ranges from 4% to 30% and is a key factor in test accuracy. NIPT uses next-generation sequencing (NGS) to count the number of DNA fragments from each chromosome. If the proportion of fragments from a particular chromosome is higher than expected, it suggests an extra copy (trisomy).

Step-by-Step: How NIPT Testing Works

1. Blood Draw: A healthcare provider collects a small sample (about 10–20 mL) of the mother’s blood, usually from a vein in the arm. No special preparation is needed.
2. DNA Extraction: The laboratory isolates the total cell-free DNA from the plasma portion of the blood.
3. Sequencing: Using massively parallel sequencing, the lab reads millions of short DNA fragments and maps them to each chromosome.
4. Bioinformatics Analysis: A computer algorithm calculates the percentage of fragments from each chromosome and compares them to a reference standard.
5. Report Generation: Results are typically available within 5–10 business days. The report indicates whether the risk for each screened condition is “low risk” or “high risk.”

What NIPT Screens For

The core NIPT panel screens for the following conditions:

• Trisomy 21 (Down syndrome) – detection rate >99%
• Trisomy 18 (Edwards syndrome) – detection rate ~97%
• Trisomy 13 (Patau syndrome) – detection rate ~90%
• Sex chromosome aneuploidies (e.g., Turner syndrome, Klinefelter syndrome) – detection rates vary
• Optional: selected microdeletions (e.g., 22q11.2 deletion syndrome) – detection rates lower, typically 80–90%

Comparison with Other Prenatal Screening Tests

Important Considerations When Choosing NIPT

Fetal Fraction and Accuracy

NIPT accuracy depends heavily on the fetal fraction. If the fraction is too low (commonly <4%), the test may not yield a result. This can happen in early gestation, with high maternal body mass index, or in certain medical conditions. Repeat blood draw is often required. Most laboratories report the fetal fraction on the result sheet.

NIPT vs. Carrier Screening

It is important to understand that NIPT screens for chromosomal abnormalities in the fetus, while carrier screening tests the parents for recessive genetic conditions (e.g., cystic fibrosis, spinal muscular atrophy, fragile X syndrome). Both are recommended by the American College of Obstetricians and Gynecologists (ACOG). Many US providers now offer a combined prenatal screening panel that includes NIPT plus expanded carrier screening for a more comprehensive risk assessment.

NIPT and Prenatal Paternity Test

NIPT is sometimes confused with a prenatal paternity test. While both use cell-free DNA, a prenatal paternity test compares fetal DNA to a potential father’s DNA. NIPT does not determine paternity; it only screens for chromosomal conditions.

When to Talk to a Genetic Counselor

If NIPT returns a high-risk result, a genetic counselor can help interpret the findings, explain the next steps, and coordinate diagnostic testing such as CVS or amniocentesis. Genetic counselors are also valuable for families with a history of genetic disorders or for those considering comprehensive screening options.

What NIPT Does NOT Do

NIPT does not detect all genetic conditions. It cannot screen for structural birth defects, such as neural tube defects, nor does it replace first-trimester ultrasound for nuchal translucency measurement. It is also not a substitute for carrier screening or diagnostic procedures. Always discuss your screening plan with your healthcare provider.

If you are ready to take a proactive step in your prenatal care, you can order a prenatal screening panel online and receive results quickly from a trusted US laboratory. This comprehensive panel combines NIPT with expanded carrier screening, giving you a clearer picture of your baby’s health—all from a simple blood draw.